Home › Kanser (lahat ng uri) › Texas › Austin
Pag-aaral pangklinika para sa Kanser (lahat ng uri) sa Austin, TX
Isang pag-aaral para sa Kanser (lahat ng uri) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Austin. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Nagre-recruitPhase 3
- Texas Oncology, Austin
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Nagre-recruitPhase 3
- Dell Seton Medical Center at The University of Texas, Austin
- University of Texas at Austin, Austin
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology, Austin
Prospective Study to Assess a Diagnostic Aid for Cancer
Nagre-recruitObservasyonal na pag-aaral
- Premier Family Physicians, Austin
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Nagre-recruitPhase 2
- Dell Medical School, University of Texas at Austin, Austin
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Nagre-recruitPhase 1/2
- NEXT Oncology ( Site 1010), Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Nagre-recruitPhase 1
- NEXT Oncology - Austin, Austin
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- USO - Texas Oncology, Austin
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Dell Children's Medical Center of Central Texas, Austin
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- Texas Oncology - Central South, Austin
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 1
- Texas Oncology - Central/South Texas /ID# 268563, Austin
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Nagre-recruitPhase 2
- Texas Oncology - Central/South Texas /ID# 275154, Austin
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Nagre-recruitPhase 2/3
- Texas Oncology - South Austin /ID# 276033, Austin
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Nagre-recruitPhase 2
- Texas Oncology - Austin Central, Austin
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Nagre-recruitPhase 2
- Texas Oncology-Austin North /ID# 279958, Austin
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Nagre-recruitPhase 1
- GSK Investigational Site, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology Austin, Austin
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Nagre-recruitPhase 1/2
- NEXT Oncology, Austin
Beat Childhood Cancer Specimen Banking and Data Registry
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Dell Children's Blood and Cancer Center, Austin
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Nagre-recruitPhase 1/2
- NEXT Austin, Austin
A Study in Patients With Advanced Cancers
Nagre-recruitPhase 1/2
- NEXT Oncology Austin, Austin
Pag-aaral para sa Kanser (lahat ng uri) sa ibang lungsod
- Houston, TX122 pag-aaral
- New York City, NY110 pag-aaral
- Boston, MA86 pag-aaral
- Los Angeles, CA73 pag-aaral
- Nashville, TN65 pag-aaral
- Washington, DC60 pag-aaral
- Philadelphia, PA60 pag-aaral
- Durham, NC59 pag-aaral
- Chicago, IL52 pag-aaral
- Seattle, WA50 pag-aaral
- Atlanta, GA50 pag-aaral
- Arlington, VA48 pag-aaral
Iba pang pag-aaral sa Austin
- Non-Small Cell Lung Cancer30 pag-aaral
- Obesity20 pag-aaral
- Colorectal Cancer19 pag-aaral
- Metastatic Cancer19 pag-aaral
- Pagkabigo ng Puso18 pag-aaral
- Overweight18 pag-aaral
- Kanser sa Suso18 pag-aaral
- Kanser sa Ovary17 pag-aaral
- Kanser ng Endometrium16 pag-aaral
- Kanser sa Prostate15 pag-aaral
- Depression14 pag-aaral
- Triple-Negative Breast Cancer13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.